80 related articles for article (PubMed ID: 18544996)
1. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
[TBL] [Abstract][Full Text] [Related]
2. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
3. [The effect of breast cancer specific gene 1 in the prognosis of breast cancer].
Wu KJ; Weng ZY; Lin GF; Wu XR; Li FM; Zhang YC
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):294-7. PubMed ID: 15842935
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
5. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.
Li Y; Wei Q; Cao F; Cao X
Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.
Ye Q; Zheng MH; Cai Q; Feng B; Chen XH; Yu BQ; Gao YB; Ji J; Lu AG; Li JW; Wang ML; Liu BY
Cancer Sci; 2008 Oct; 99(10):1924-32. PubMed ID: 19016751
[TBL] [Abstract][Full Text] [Related]
7. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
8. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
10. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
11. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji H; Liu YE; Jia T; Wang M; Liu J; Xiao G; Joseph BK; Rosen C; Shi YE
Cancer Res; 1997 Feb; 57(4):759-64. PubMed ID: 9044857
[TBL] [Abstract][Full Text] [Related]
12. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.
Van der Auwera I; Bovie C; Svensson C; Trinh XB; Limame R; van Dam P; van Laere SJ; van Marck EA; Dirix LY; Vermeulen PB
BMC Cancer; 2010 Mar; 10():97. PubMed ID: 20226036
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of the interleukin-10 gene in breast cancer tissues.
Son KS; Kang HS; Kim SJ; Jung SY; Min SY; Lee SY; Kim SW; Kwon Y; Lee KS; Shin KH; Ro J
Breast; 2010 Dec; 19(6):484-8. PubMed ID: 20646924
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Methylation Levels for the Breast Cancer Associated Genes
Li J; Li P; Li J; Yang H; Liu G; Shen P; Jiang G
Genet Test Mol Biomarkers; 2022 Sep; 26(9):422-429. PubMed ID: 36166741
[No Abstract] [Full Text] [Related]
15. Estrogen receptor gene methylation in human breast tumors.
Falette NS; Fuqua SA; Chamness GC; Cheah MS; Greene GL; McGuire WL
Cancer Res; 1990 Jul; 50(13):3974-8. PubMed ID: 2354445
[TBL] [Abstract][Full Text] [Related]
16. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.
Chen Y; Zhou J; Xu Y; Li Z; Wen X; Yao L; Xie Y; Deng D
Cancer Sci; 2009 Sep; 100(9):1663-7. PubMed ID: 19522853
[TBL] [Abstract][Full Text] [Related]
19. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
20. NOEY2 mutations in primary breast cancers and breast hyperplasia.
Yang J; Hu A; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T
Breast; 2009 Jun; 18(3):197-203. PubMed ID: 19482475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
